Phosphorylated Proteins in Lung Cancer
Author Information
Author(s): Gong Y, Hirano T, Kato Y, Yoshida K, Shou Y, Ohira T, Ikeda N, Ebihara Y, Kato H
Primary Institution: Tokyo Medical University
Hypothesis
To evaluate the relationship between phosphorylated tyrosine-containing proteins and clinicopathological factors, cell proliferation, and outcomes in non-small cell lung cancer.
Conclusion
Phosphorylated tyrosine-containing proteins in non-small cell lung cancer tissues reflect biological malignancy and may be valuable for therapeutic strategies.
Supporting Evidence
- Phosphorylated tyrosine-containing proteins were detected in 74% of lung cancer cases.
- High expression of these proteins correlated with poor disease-free survival.
- Statistically significant differences were found between normal and cancerous tissues.
Takeaway
This study found that certain proteins in lung cancer can help doctors understand how aggressive the cancer is and how well patients might do after surgery.
Methodology
The study used immunohistochemical evaluation of surgically resected materials from patients with non-small cell lung cancer to assess protein expression levels.
Limitations
The study focused only on non-small cell lung cancer and may not be applicable to other types of lung cancer.
Participant Demographics
Patients with non-small cell lung cancer, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
Statistical Information
P-Value
P<0.0001; P(Low, High)<0.0001; P(Low, Int)<0.0001; P(Int, High)<0.0001; P(Low, Int)<0.0028; P(Low, High)=0.0002
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website